Responses

Download PDFPDF

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Meta-analysis

    Dear Editor

    I was excited by this study which shows a decline in the rate of decline in lung function in COPD with inhaled steroids. Although small, this effect could be significant over time, with the potential to delay the onset of debilitating symptoms with this disease. However, the study seems to use similar methadology to a recently published study in another journal which reached the opposite conclusion.[1]...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Do inhaled corticosteroids slow FEV1 decline in COPD after all?

    Dear Editor

    I question the findings of this meta-analysis[1] and the content of the associated editorial.[2] The meta-analysis has drawn from available long-term data from randomised-controlled studies (RCTs) into inhaled corticosteroids (ICS) in chronic obstructive airways disease (COPD). The whole purpose of meta-analysis is to systematically analyse such data to answer a question. This study seems to selectively...

    Show More
    Conflict of Interest:
    None declared.